Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 54.00 | 109.75 | 0.4920 | 0.0790 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 129.00 | 109.75 | 1.1754 | 1.3020 | |
| BT-20 | PLX-4720 | 19.9526 | uM | 3 | 156.25 | 49.48 | 69.00 | 109.75 | 0.6287 | 0.3356 |
| BT-20 | Nilotinib | 3.1623 | uM | 3 | 156.25 | 49.48 | 127.00 | 109.75 | 1.1572 | 1.2709 |
| BT-20 | Etoposide | 0.0033113 | uM | 3 | 156.25 | 49.48 | 104.00 | 109.75 | 0.9476 | 0.9085 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 156.25 | 49.48 | 124.00 | 109.75 | 1.1298 | 1.2241 |
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 156.25 | 49.48 | 127.00 | 109.75 | 1.1572 | 1.2709 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 156.25 | 49.48 | 77.00 | 109.75 | 0.7016 | 0.4693 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 156.25 | 49.48 | 124.00 | 109.75 | 1.1298 | 1.2241 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 156.25 | 49.48 | 125.00 | 109.75 | 1.1390 | 1.2397 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 156.25 | 49.48 | 146.00 | 109.75 | 1.3303 | 1.5637 |
| BT-20 | NVP-TAE684 | 0.01 | uM | 3 | 156.25 | 49.48 | 120.00 | 109.75 | 1.0934 | 1.1616 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 126.00 | 109.75 | 1.1481 | 1.2553 | |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 156.25 | 49.48 | 116.00 | 109.75 | 1.0569 | 1.0987 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 132.00 | 109.75 | 1.2027 | 1.3485 | |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 156.25 | 49.48 | 116.00 | 109.75 | 1.0569 | 1.0987 |
| BT-20 | Etoposide | 0.01 | uM | 3 | 156.25 | 49.48 | 147.00 | 109.75 | 1.3394 | 1.5790 |
| BT-20 | Etoposide | 1 | uM | 3 | 156.25 | 49.48 | 84.00 | 109.75 | 0.7654 | 0.5849 |
| BT-20 | PLX-4720 | 10 | uM | 3 | 156.25 | 49.48 | 100.00 | 109.75 | 0.9112 | 0.8445 |
| BT-20 | Etoposide | 10 | uM | 3 | 156.25 | 49.48 | 95.00 | 109.75 | 0.8656 | 0.7640 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 156.25 | 49.48 | 114.00 | 109.75 | 1.0387 | 1.0672 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 156.25 | 49.48 | 107.00 | 109.75 | 0.9749 | 0.9563 |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 66.00 | 109.75 | 0.6014 | 0.2849 | |
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 54.00 | 109.75 | 0.4920 | 0.0790 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 235.00 | 299.75 | 0.7840 | 0.6139 |